Briefing

Industry news

Industry briefing

NEWS

US to buy additional Novavax Covid-19 vaccine doses

The US government has modified the existing agreement with Novavax to secure additional doses of its Covid-19 vaccine.

Industry news

Industry briefing

02/24/2023 11:20:44
  • Home | ‘Right shoring’ API production in Europe
  • In this issue
  • Contents
  • Mimotopes Company Insight
  • Mimotopes
  • Briefing
  • Industry news
  • The pharma industry briefing
  • HOF Sonderanlagenbau
  • BEA Technologies
  • Comment
  • 4D Molecular’s Fabry gene therapy program on FDA clinical hold
  • Price is key for wider market adoption of Amgen’s Amjevita
  • Wegovy: the latest weight loss fad
  • PROTAC development gains momentum, but clinical performance is poor
  • FDA head Califf on tighter accelerated approvals and lower drug prices
  • In Depth
  • ‘Right shoring’ API production in Europe
  • Provention’s Tzield can delay type 1 diabetes. But will it reach all patients?
  • DCTs in 2023: New year’s resolutions for decentralised clinical trials
  • Inside the hunt for an Alzheimer’s disease vaccine
  • Are we entering the era of biologics for COPD?
  • CMO Moves: Regulatory catalysts for drug manufacturing – February
  • Events
  • Next issue